CV vs NVST · rev $3.5M vs P/E 56, rev $2.51B
CapsoVision, Inc. Common Stock (CV) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
Latest reported NVST revenue for 2024-12-31 was $2.51B. Net income was -$1.12B. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
CV currently screens at market cap $359.2M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the CV and NVST stock pages for the full models.
Not investment advice.